Acta Vet. Brno 2022, 91: 217-226

https://doi.org/10.2754/avb202291030217

In field review of Bovalto® Respi 3 and 4 efficacy in different production systems

Matthew Yarnall1, Edmond Jolivet2, Mathieu Chevalier2, Arnaud Bolon2, Marie-Pascale Tiberghien3, Milan Huňady4, Corinne Philippe2

1Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany
2Boehringer Ingelheim, Lyon, France
3Consulting, Cortambert, France
4Bioveta, Ivanovice na Hané, Czech Republic

Received November 17, 2021
Accepted June 14, 2022

References

1. Assié S, Seegers H, Makoschey B, Désiré-Bousquié L, Bareille N 2009: Exposure to pathogens and incidence of respiratory disease in young bulls on their arrival at fattening operations in France. Vet Rec 165: 195-199 <https://doi.org/10.1136/vr.165.7.195>
2. Chamorro MF, Palomares RA 2020: Bovine respiratory disease vaccination against viral pathogens, modified-live versus inactivated antigen vaccines, intranasal versus parenteral, what is the evidence? Vet Clin Food Anim 36: 461-472 <https://doi.org/10.1016/j.cvfa.2020.03.006>
3. Chamorro MF, Woolums A, Waltz PH 2016: Vaccination of calves against common respiratory viruses in the face of maternally derived antibodies (IFOMA). Anim Health Res Rev 17: 79-84 <https://doi.org/10.1017/S1466252316000013>
4. Cooke RF, Paiva R, Pohler KG 2020: Technical note: Using enzyme-linked immunosorbent assays to evaluate humoral responses to vaccination against respiratory viruses in beef cattle. J Anim Sci 98: skaa249 <https://doi.org/10.1093/jas/skaa249>
5. Ellis J, Gow S, Berenik A, Lacoste S, Erickson N 2018: Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves. Can Vet J 59: 1311-1319
6. EMEA/CVMP/852/99 2001: Note for Guidance Field Trials with Veterinary Vaccines. London, UK. 8 p. Available at https://www.ema.europa.eu/en/documents/scientific-guideline/note-guidance-field-trials-veterinary-vaccines_en.pdf
7. Houe H 1999: Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet Microbiol 64: 89-107 <https://doi.org/10.1016/S0378-1135(98)00262-4>
8. Inman C, Hudson C 2009: Cattle immunology: vaccination and immunological testing. UK Vet 14: 1-4
9. Kurcubic V, Dokovic R, Ilic Z, Petrovic M 2018: Etiopathogenesis and economic significance of bovine respiratory disease complex (BRDC). Acta Agric Serb 23: 85-100 <https://doi.org/10.5937/AASer1845085K>
10. Marie A 2016: Comparaison de l’efficacité en condition terrain de deux vaccins contre les bronchopneumonies infectieuses chez les jeunes bovins en ateliers d’engraissement. Thčse de Doctorat Vétérinaire, Faculté de Médecine, Nantes, F, 122 p.
11. Metcalfe L, Philippe-Reversat C, Esteves Lopes R, Chevalier M 2019: Booster effect of an inactivated quadrivalent BRD vaccine following an intra-nasal inoculation: leading them by the nose - Poster presented at the European Bovine Congress (EBC), ‘s-Hertogenbosch, The Netherlands Sept 11-13, 2019
12. Metcalfe LVA 2019: An update on the status of BVD control and eradication in Europe. J Veter Sci Med 7: 4
13. Smith RA, Step DL, Woolums AR 2020: Bovine respiratory disease: looking back and looking forward, what do we see? Vet Clin North Am Food Anim Pract 36: 239-251 <https://doi.org/10.1016/j.cvfa.2020.03.009>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Indexed in DOAJ

Archive